ArticleJournal of epidemiology and global health2025
Indications for Pediatric Enucleations of Non-Retinoblastoma Globes in Saudi Arabia with Clinical and Radiological Correlation To Final Histopathological Diagnosis.
Article in Journal of epidemiology and global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEnucleation is a difficult surgical decision in the ophthalmic practice. The overall commonest indications for this procedure are intraocular neoplasm (mostly retinoblastoma in children and uveal melanoma in adults), trauma, painful blind eyes, phthisis bulbi, and microphthalmos for cosmetic restoration of the orbital size. Specific indications vary according to age groups, gender, and geographical areas. In this study we aim to investigate the indications -other than retinoblastoma- for enucleation in the pediatric age group to observe the trends and significant associations of these indications with our demographic and social background.
methodsA retrospective cohort study of non-retinoblastoma globes based on histopathological examination obtained from pediatric patients younger than 18 years of age in a tertiary eye hospital over the period 2000 to 2021. Descriptive analysis was used as well as comparative analysis to highlight the differences between clinical, radiological, and final histopathological diagnoses and to correlate different ophthalmic indications to age and gender. We also investigated the accuracy of clinical and radiological evaluation with special attention to the misdiagnosis of retinoblastoma.
resultsA total of 47 enucleated globes from 47 patients were included in the study with the majority being in the younger age group of three years or less (40.4%). Males constituted 57.4% of the cohort and the remaining 42.6% were females. Ruptured globe was the main clinical indication in about half of the enucleations followed by painful blind or phthisical eyes. Traumatic enucleations were significantly associated with older age group of 7 years or older (p = < 0.001). Interestingly, four globes and three globes were mis-diagnosed as retinoblastoma clinically and radiologically respectively and were accurately diagnosed after histopathological examination of the enucleated globes.
conclusionEye trauma is a leading cause for pediatric enucleation in about half of the non-retinoblastoma globes with higher prevalence in older children. When combined with end stage traumatized globes presenting as painful blind eye or phthisis bulbi, the rate increases to 57.4% of the enucleations. Health awareness and safety measures during sports and other activities should be implemented. Ophthalmologists should be aware of ophthalmic diseases presenting as pseudoretinoblastoma leading to possible unnecessary enucleations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.